EFM
VERV
E Fund Management’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,522
| Closed | -$48.1K | – | 428 |
|
|
2025
Q1 | $48.1K | Buy |
+10,522
| New | +$48.1K | ﹤0.01% | 394 |
|
|
2024
Q4 | – | Sell |
-13,554
| Closed | -$65.6K | – | 413 |
|
|
2024
Q3 | $65.6K | Buy |
+13,554
| New | +$65.6K | ﹤0.01% | 347 |
|
|
2024
Q2 | – | Sell |
-20,394
| Closed | -$271K | – | 380 |
|
|
2024
Q1 | $271K | Buy |
20,394
+4,016
| +25% | +$53.3K | 0.02% | 291 |
|
|
2023
Q4 | $228K | Buy |
16,378
+1,981
| +14% | +$27.6K | 0.01% | 264 |
|
|
2023
Q3 | $191K | Buy |
14,397
+1,499
| +12% | +$19.9K | 0.01% | 263 |
|
|
2023
Q2 | $242K | Sell |
12,898
-2,038
| -14% | -$38.2K | 0.02% | 254 |
|
|
2023
Q1 | $215K | Sell |
14,936
-4,587
| -23% | -$66K | 0.02% | 286 |
|
|
2022
Q4 | $378K | Buy |
19,523
+7,231
| +59% | +$140K | 0.03% | 193 |
|
|
2022
Q3 | $422K | Buy |
+12,292
| New | +$422K | 0.04% | 169 |
|
|
2022
Q2 | – | Sell |
-9,282
| Closed | -$212K | – | 350 |
|
|
2022
Q1 | $212K | Buy |
+9,282
| New | +$212K | 0.01% | 283 |
|